Antimalarial activity of mefloquine and qinghaosu (Q34246854)

31 July 2017

Antimalarial activity of mefloquine and qinghaosu (English)

1 reference

31 July 2017

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6124713

9 August 2023

author name string

J. B. Jiang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6124713

9 August 2023

G. Q. Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6124713

9 August 2023

X. B. Guo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6124713

9 August 2023

Y. C. Kong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6124713

9 August 2023

K. Arnold

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6124713

9 August 2023

language of work or name

English

0 references

publication date

1 August 1982

1 reference

31 July 2017

7 August 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6124713

full work available at URL

9 August 2023

https://api.elsevier.com/content/article/PII:S0140673682902689?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)90268-9

https://api.elsevier.com/content/article/PII:S0140673682902689?httpAccept=text/plain

9 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)90268-9

9 August 2023

1 reference

31 July 2017

2

1 reference

31 July 2017

8293

1 reference

31 July 2017

285-288

1 reference

A comparative evaluation of sulfalene-trimethoprim and sulphormethoxine-pyrimethamine against falciparum malaria in Thailand

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990268-9

7 January 2021

Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990268-9

7 January 2021

Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990268-9

7 January 2021

Drug therapy for Plasmodium falciparum malaria resistant to pyrimethamine-sulfadoxine (Fansidar). A study of alternate regimens in Eastern Thailand, 1980.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990268-9

7 January 2021

Kinetics of a new antimalarial, mefloquine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990268-9

7 January 2021

A simple qualitative test for chloroquine in urine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990268-9

7 January 2021

Mefloquine (WR 142,490) in the Treatment of Human Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990268-9

7 January 2021

The treatment of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990268-9

7 January 2021

Antimalaria studies on Qinghaosu

10

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)90268-9

9 August 2023

Identifiers

1 reference

31 July 2017

1 reference